chr22-23877857-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024939.4(SLC2A11):c.682G>A(p.Ala228Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000202 in 1,611,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024939.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A11 | NM_001024939.4 | c.682G>A | p.Ala228Thr | missense_variant | 6/12 | ENST00000316185.9 | NP_001020110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A11 | ENST00000316185.9 | c.682G>A | p.Ala228Thr | missense_variant | 6/12 | 1 | NM_001024939.4 | ENSP00000326748.8 | ||
ENSG00000251357 | ENST00000433835.3 | c.431+686G>A | intron_variant | 5 | ENSP00000400325.3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000101 AC: 25AN: 247008Hom.: 0 AF XY: 0.000135 AC XY: 18AN XY: 133744
GnomAD4 exome AF: 0.000206 AC: 301AN: 1459342Hom.: 0 Cov.: 31 AF XY: 0.000207 AC XY: 150AN XY: 725938
GnomAD4 genome AF: 0.000164 AC: 25AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.694G>A (p.A232T) alteration is located in exon 7 (coding exon 6) of the SLC2A11 gene. This alteration results from a G to A substitution at nucleotide position 694, causing the alanine (A) at amino acid position 232 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at